Long term efficacy of Metreleptin and its effect of nocturnal luteinising hormone (LH) in patients with Lipodystrophy

Trial Profile

Long term efficacy of Metreleptin and its effect of nocturnal luteinising hormone (LH) in patients with Lipodystrophy

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Metreleptin (Primary)
  • Indications Lipodystrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2017 New trial record
    • 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top